With the publication of the European Good Distribution Practices(GDP) guideline, to better protect the pharmaceutical supply chain -referencing EMA Guidelines in 2013 – all actors in the pharmaceuticalsupply chain are obliged to perform a full review of all associated QualitySystems to determine current compliance status, as well as addressgaps, thus ensuring compliance in accordance with the guideline.

Source: Pharmaceutical Supply Chain Security Risk Assessment for Shipping Lanes | Pharmaceutical Outsourcing – The Journal of Pharmaceutical & Biopharmaceutical Contract Services